Co-Authors
This is a "connection" page, showing publications co-authored by Hualiang Jiang and Kaixian Chen.
Connection Strength
1.025
-
Carboxyl terminus of severe acute respiratory syndrome coronavirus nucleocapsid protein: self-association analysis and nucleic acid binding characterization. Biochemistry. 2006 Oct 03; 45(39):11827-35.
Score: 0.086
-
An overall picture of SARS coronavirus (SARS-CoV) genome-encoded major proteins: structures, functions and drug development. Curr Pharm Des. 2006; 12(35):4539-53.
Score: 0.081
-
Techniques used for the discovery of therapeutic compounds: The case of SARS. Drug Discov Today Technol. 2006; 3(3):277-83.
Score: 0.081
-
Severe acute respiratory syndrome coronavirus membrane protein interacts with nucleocapsid protein mostly through their carboxyl termini by electrostatic attraction. Int J Biochem Cell Biol. 2006; 38(4):589-99.
Score: 0.081
-
SR-rich motif plays a pivotal role in recombinant SARS coronavirus nucleocapsid protein multimerization. Biochemistry. 2005 Nov 22; 44(46):15351-8.
Score: 0.081
-
Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J Virol. 2005 Jun; 79(11):7095-103.
Score: 0.078
-
The nucleocapsid protein of SARS coronavirus has a high binding affinity to the human cellular heterogeneous nuclear ribonucleoprotein A1. FEBS Lett. 2005 May 09; 579(12):2623-8.
Score: 0.077
-
Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A. Biochem Biophys Res Commun. 2004 Aug 27; 321(3):557-65.
Score: 0.074
-
Molecular cloning, expression, purification, and mass spectrometric characterization of 3C-like protease of SARS coronavirus. Protein Expr Purif. 2003 Dec; 32(2):302-8.
Score: 0.070
-
A 3D model of SARS_CoV 3CL proteinase and its inhibitors design by virtual screening. Acta Pharmacol Sin. 2003 Jun; 24(6):497-504.
Score: 0.068
-
Small envelope protein E of SARS: cloning, expression, purification, CD determination, and bioinformatics analysis. Acta Pharmacol Sin. 2003 Jun; 24(6):505-11.
Score: 0.068
-
Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2. J Med Chem. 2022 02 24; 65(4):2794-2808.
Score: 0.059
-
Residues on the dimer interface of SARS coronavirus 3C-like protease: dimer stability characterization and enzyme catalytic activity analysis. J Biochem. 2008 Apr; 143(4):525-36.
Score: 0.023
-
Mutation of Gly-11 on the dimer interface results in the complete crystallographic dimer dissociation of severe acute respiratory syndrome coronavirus 3C-like protease: crystal structure with molecular dynamics simulations. J Biol Chem. 2008 Jan 04; 283(1):554-564.
Score: 0.023
-
pH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro)) dimer: molecular dynamics simulations and multiple X-ray structure analyses. J Mol Biol. 2005 Nov 18; 354(1):25-40.
Score: 0.020
-
Severe acute respiratory syndrome coronavirus 3C-like proteinase N terminus is indispensable for proteolytic activity but not for enzyme dimerization. Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations. J Biol Chem. 2005 Jan 07; 280(1):164-73.
Score: 0.019
-
Putative hAPN receptor binding sites in SARS_CoV spike protein. Acta Pharmacol Sin. 2003 Jun; 24(6):481-8.
Score: 0.017
-
Identification of probable genomic packaging signal sequence from SARS-CoV genome by bioinformatics analysis. Acta Pharmacol Sin. 2003 Jun; 24(6):489-96.
Score: 0.017